stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. DXCM
    stockgist
    HomeTop MoversCompaniesConcepts
    DXCM logo

    DexCom, Inc.

    DXCM
    NASDAQ
    Healthcare
    Medical - Devices
    San Diego, CA, US10,200 employeesdexcom.com
    $62.22
    -0.15(-0.24%)

    Mkt Cap $24.3B

    $54.84
    $89.53

    52-Week Range

    At a Glance

    AI-generated

    DexCom, Inc.

    8-K
    DexCom, Inc. reported Q4 2025 revenue of $1.260 billion, up 13% year-over-year, GAAP operating income of $323.0 million (25.6% of revenue), and full-year 2025 revenue of $4.662 billion, up 16%. The company reiterated 2026 revenue guidance of $5.16-$5.25 billion and highlighted launches of Dexcom G7 15 Day CGM and Dexcom Smart Basal.

    $24.3B

    Market Cap

    $4.7B

    Revenue

    $843M

    Net Income

    Employees10,200
    Fundamentals

    How The Business Makes Money

    Revenue by Geography

    US71.9%($17.7B)
    Non Us28.1%($6.9B)
    Activity

    What Changed Recently

    Management Change
    Mar 1, 2026

    . DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. As previous

    Management Change
    Feb 25, 2026

    . DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On February

    Financial Results
    Feb 11, 2026

    , including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the

    Financial Results
    Jan 11, 2026

    , including Exhibits 99.1 and 99.2 hereto, is furnished shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    TEVATeva Pharmaceutical Indus...$30.07-0.61%$35.0B23.2
    BIIBBiogen Inc.$177.12-3.63%$26.0B20.8
    PHGKoninklijke Philips N.V.$27.08-0.77%$26.0B24.5
    LHLabcorp Holdings Inc.$274.19+0.53%$22.7B24.9
    STESTERIS plc$218.35-0.72%$21.4B30.7
    WSTWest Pharmaceutical Servi...$255.29+1.01%$18.4B35.4
    WATWaters Corporation$304.52+1.54%$18.1B28.0
    ZBHZimmer Biomet Holdings, I...$90.72-0.34%$18.0B24.6
    Analyst View
    Company Profile
    CIK0001093557
    ISINUS2521311074
    CUSIP252131107
    Phone858 200 0200
    Address6340 Sequence Drive, San Diego, CA, 92121, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice